TO STUDY THE EFFECT OF DEXMEDETOMIDINE INFUSION IN ENT SURGERIES UNDER GENERAL ANAESTHESIA
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2023/03/050368
- Lead Sponsor
- kastruba medical college Mangalore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1&2
patient undergoing Elective ENT surgeries under general anaesthesia
Exclusion Criteria
ASA 3 and above
patient not willing to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of hemodynamic parameters <br/ ><br>Like <br/ ><br>Heart rate <br/ ><br>Systolic blood pressure <br/ ><br>Diastolic blood pressure <br/ ><br>Mean arterial blood pressureTimepoint: 0mim <br/ ><br>15min <br/ ><br>30min <br/ ><br>45min <br/ ><br>1hour <br/ ><br>1hour15min <br/ ><br>1hour30min <br/ ><br>1hour45min <br/ ><br>2hour <br/ ><br>2hour15min <br/ ><br>2hour30min <br/ ><br>2hour45min <br/ ><br>3hour
- Secondary Outcome Measures
Name Time Method Assessment of Anaesthetic drug dose <br/ ><br>Required for induction <br/ ><br>intraoperative Blood loss <br/ ><br>Recovery time after Anaesthesia <br/ ><br>Post operative analgesic requirementTimepoint: 0mim <br/ ><br>15min <br/ ><br>30min <br/ ><br>45min <br/ ><br>1hour <br/ ><br>1hour15min <br/ ><br>1hour30min <br/ ><br>1hour45min <br/ ><br>2hour <br/ ><br>2hour15min <br/ ><br>2hour30min <br/ ><br>2hour45min <br/ ><br>3hour
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of DEXMEDETOMIDINE affect hemodynamics during ENT surgeries under general anesthesia?
How does DEXMEDETOMIDINE infusion compare to standard-of-care agents in maintaining hemodynamic stability during ENT procedures?
Are there specific biomarkers that predict optimal DEXMEDETOMIDINE response in ENT surgery patients under general anesthesia?
What are the potential adverse events associated with DEXMEDETOMIDINE infusion in ENT surgeries and how can they be managed?
What alternative adjuvant drugs or combination therapies are being explored for hemodynamic management in ENT surgeries similar to CTRI/2023/03/050368?